HLA-DRB1 alleles are associated with the clinical course of disease and steroid dependence in Mexican patients with ulcerative colitis

Colorectal Disease

Volumn 12, Issue 12, 2010, Pages 1231-1235

  Yamamoto Furusho, J K ^a   Rodriguez Bores L ^a   Granados, J ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Clinical course; HLA; Steroid dependence; UC

Indexed keywords

HLA DR ANTIGEN; PREDNISONE; STEROID;

ADULT; ALLELE; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DOT HYBRIDIZATION; DRUG DEPENDENCE; FEMALE; HISPANIC; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; ALLELES; COLITIS, ULCERATIVE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; MALE; MEXICO; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; STEROIDS;

EID: 78349244400     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.02025.x     Document Type: Article

References (28)

1. Tysk C, Lindberg E, Järnerot G, Flodérus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 29: 990-6.
2. Asakura H, Tsuchiya M, Aiso S. Association of the human leukocyte DR2 antigen with Japanese ulcerative colitis. Gastroenterology 1982; 82: 413-8.
3. Yamamoto-Furusho JK. Inmunogenética de la colitis ulcerosa crónica inespecífica. Rev Invest Clin 2003; 55: 705-10.
4. Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an anti-neutrophil cytoplasmic antibody positive subgroup. Gastroenterology 1995; 108: 423-7.
5. Toyoda H, Wang SJ, Yang H. Distinct association of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104: 741-8.
6. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996; 347: 1212-7.
7. Delpre G, Kadish U, Gazit E. HLA antigens in ulcerative colitis and Crohn's disease in Israel. Gastroenterology 1980; 78: 1452-7.
8. Ahmad T, Marshall S, Jewell D. Genetics inflammatory bowel disease: the role of the HLA complex. World J Gastroenterol 2006; 12: 3628-35.
9. Rodriguez-Bores L, Fonseca GC, Villeda MA, Yamamoto-Furusho JK. Novel genetic markers in inflammatory bowel disease. World J Gastroenterol 2007; 13: 5560-70.
10. Habeeb MA, Rajalingam R, Dhar A, Kumar A, Sharma MP, Mehra NK. HLA association and ocurrence of autoantibodies in Asian Indian patients with ulcerative colitis. Am J Gastroenterol 1997; 92: 772-6.
11. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, Ruiz-Morales JA, Higuera L, Cutiño T, Rodriguez-Perez JM, Villareal-Garza C, Granados J. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Hum Immunol 2003; 64: 119-23.
12. Stokkers PC, Reitsma PH, Van Tytgat GN, Deventer SJ. HLA-DR and DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999; 45: 395-401.
13. Perri F, Annese V, Piepoli A, Napolitano G, Lombardi G, Ciavarella G, Di Giorgio G, Andruilli A. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol 1998; 30: 56-61.
14. Bekker-Mendez C, Yamamoto-Furusho JK, Vargas-Alarcon G, Ize-Ludlow D, Alcocer-Varela J, Granados J. Haplotype distribution of class II MHC genes in Mexican patients with systemic lupus erythematosus. Scand J Rheumatol 1998; 27: 373-6.
15. Satsangi J, Silverberg MS, Vermiere S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-53.
16. Henriksen M, Jahnsen J, Lygren I, Sauar J, Kjellevold O, Schulz T, Vatn MH, Moum B, IBSEN Study Group. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis 2006; 12: 543-50.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
18. Charron: Genetic Diversity of HLA Functional and Medical Implication (1997). Proceeding of the 12th International Histocompatibility Workshop and Conference 1997. EDK, Medical and Scientific International Publisher, Paris, France.
19. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993; 5: 1461-71.
20. Yamamoto-Furusho JK, Uscanga-Domínguez L, Lopez-Martinez A, Granados J. Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis. World J Gastroenterol 2006; 12: 1617-20.
21. Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 1995; 108: 423-7.
22. Heresbach D, Alizadeh M, Reumaux D, Colombel JF, Delamaire M, Danze PM, Gosselin I, Gennet B, Bretagne JF, Semana G. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis? J Autoimmun 1996; 9: 777-84.
23. Myung SJ, Yang SK, Jung HY, Chang HS, Park B, Hong WS, Kim JH, Min I. HLA-DRB1*1502 confers susceptibility to ulcerative colitis but is negatively associated with its intractability. Int J Colorectal Dis 2002; 17: 233-7.
24. Granados J, Vargas-Alarcón G, Drenkard C, Andrade F, Melín-Aldana H, Alcocer-Varela J, Alarcón-Segovia D. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE). Lupus 1997; 6: 57-62.
25. Vargas-Alarcón G, Gamboa R, Zuñiga J, Hernández-Pacheco G, Ramos-Kuri M, Castillo E, Gomez-Casado E, Martinez-Laso J, Arnaiz-Villena A, Granados J. HLA-DRB1*04 allele frequencies on Indian and Mestizo population from Mexico. Hum Immunol 2000; 6: 35-9.
26. Yap LM, Ahmad T, Jewell DP. The contribution of HLA genes to IBD susceptibility and phenotype. Best Pract Res Clin Gastroenterol 2004; 18: 577-96.
27. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998; 42: 387-91.
28. Orchard TR, Satsangi J, Van HeelD, Jewell DP. Genetics of inflammatory bowel disease: a reappraisal. Scand J Immunol 2000; 51: 10-7.